Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
  2. Davar, Diwakar; Morrison, Robert M; Dzutsev, Amiran K; Karunamurthy, Arivarasan; Chauvin, Joe-Marc; Amatore, Florent; Deutsch, Julie S; Das Neves, Rodrigo X; Rodrigues,Richard; McCulloch, John A; Wang, Hong; Hartman, Douglas J; Badger, Jonathan H; Fernandes, Miriam R; Bai, Yulong; Sun, Jie; Cole, Alicia M; Aggarwal, Poonam; Fang, Jennifer R; Deitrick, Christopher; Bao, Riyue; Duvvuri, Umamaheswar; Sridharan, Shaum S; Kim, Seungwon W; A Choudry, Haroon; Holtzman, Matthew P; Pingpank, James F; O'Toole, James Patrick; DeBlasio, Richelle; Jin, Yang; Ding, Quanquan; Gao, Wentao; Groetsch, Christopher; Pagliano, Ornella; Rose, Amy; Urban, Corey; Singh, Jagjit; Divarkar, Prajan; Mauro, David; Bobilev, Dmitri; Wooldridge, James; Krieg, Arthur M; Fury, Matthew G; Whiteaker, Jeffrey R; Zhao, Lei; Paulovich, Amanda G; Najjar, Yana G; Luke, Jason J; Kirkwood, John M; Taube, Janis M; Park, Hyun Jung; Trinchieri, Giorgio; Zarour, Hassane M
  3. Cancer Cell. 2024, Oct 30;
  1. 2.   PDCD4 regulates axonal growth by translational repression of neurite growth-related genes and is modulated during nerve injury responses
  2. Di Paolo, Andres Pablo; Eastman, Guillermo; Mesquita Ribeiro, Raquel; Farias, Joaquina; Macklin, Andrew; Kislinger, Thomas; Colburn, Nancy; Munroe, David; Sotelo Sosa, Jose Roberto; Dajas Bailador, Federico; Sotelo Silveira, Jose Roberto
  3. RNA (New York, N.Y.). 2020, NOV; 26(11): 1637-+.
  1. 3.   Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation
  2. Schmid, T.; Bajer, M. M.; Blees, J. S.; Eifler, L. K.; Milke, L.; Rubsamen, D.; Schulz, K.; Weigert, A.; Baker, A. R.; Colburn, N. H.; Brune, B.
  3. Carcinogenesis. 2011, Oct; 32(10): 1427-1433.
  1. 4.   Actinopolysporins A-C and Tubercidin as a Pdcd4 Stabilizer from the Halophilic Actinomycete Actinopolyspora erythraea YIM 90600
  2. Zhao, L. X.; Huang, S. X.; Tang, S. K.; Jiang, C. L.; Duan, Y. W.; Beutler, J. A.; Henrich, C. J.; McMahon, J. B.; Schmid, T.; Blees, J. S.; Colburn, N. H.; Rajski, S. R.; Shen, B.
  3. Journal of Natural Products. 2011, Sep; 74(9): 1990-1995.
  1. 5.   Downregulation of Programmed Cell Death 4 by Inflammatory Conditions Contributes to the Generation of the Tumor Promoting Microenvironment
  2. Yasuda, M.; Schmid, T.; Rubsamen, D.; Colburn, N. H.; Irie, K.; Murakami, A.
  3. Molecular Carcinogenesis. 2010, Sep; 49(9): 837-848.
  1. 6.   Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion
  2. Santhanam, A. N.; Baker, A. R.; Hegamyer, G.; Kirschmann, D. A.; Colburn, N. H.
  3. Oncogene. 2010, Jul; 29(27): 3921-3932.
  1. 7.   Development of a High-Throughput Cell-Based Reporter Assay to Identify Stabilizers of Tumor Suppressor Pdcd4
  2. Blees, J. S.; Schmid, T.; Thomas, C. L.; Baker, A. R.; Benson, L.; Evans, J. R.; Goncharova, E. I.; Colburn, N. H.; McMahon, J. B.; Henrich, C. J.
  3. Journal of Biomolecular Screening. 2010, Jan; 15(1): 21-29.
  1. 8.   Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice
  2. Hwang, S. K.; Jin, H.; Kwon, J. T.; Chang, S. H.; Kim, T. H.; Cho, C. S.; Lee, K. H.; Young, M. R.; Colburn, N. H.; Beck, G. R.; Yang, H. S.; Cho, M. H.
  3. Gene Therapy. 2007, Sep; 14(18): 1353-1361.
  1. 9.   Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors
  2. Leupold, J. H.; Yang, H. S.; Colburn, N. H.; Asangani, I.; Post, S.; Allgayer, H.
  3. Oncogene. 2007, Jul; 26(31): 4550-4562.
  1. 10.   S6K1- and beta TRCP-mediated degradation of PDCD4 promotes protein translation and cell growth
  2. Dorrello, N. V.; Peschiaroli, A.; Guardavaccaro, D.; Colburn, N. H.; Sherman, N. E.; Pagano, M.
  3. Science. 2006, Oct; 314(5798): 467-471.
  1. 11.   Epidermal expression of the translation inhibitor Pdcd4 suppresses tumorigenesis
  2. Jansen, A. P.; Colburn, N. H.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2714S-2715S.
  1. 12.   Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI
  2. Zakowicz, H.; Yang, H. S.; Stark, C.; Wlodawer, A.; Laronde-Leblanc, N.; Colburn, N. H.
  3. Rna-a Publication of the Rna Society. 2005, MAR; 11(3): 261-274.
  1. 13.   All-trans-retinoic acid (ATRA) and arsenic trioxide-induced expression and regulation of programmed cell death 4 (PDCD4) in acute promyelocytic leukemia
  2. Ozpolat, B.; Tirado-Gomez, M.; Colburn, N. H.; Berestein, G. L.
  3. Blood. 2004, NOV 16; 104(11, Part 1, Abstract 886): 253A-253A.
  1. 14.   Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity
  2. Jansen, A. P.; Camalier, C. E.; Stark, C.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2004 3(2): 103-110.
  1. 15.   A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A
  2. Yang, H. S.; Cho, M. H.; Zakowicz, H.; Hegamyer, G.; Sonenberg, N.; Colburn, N. H.
  3. Molecular and Cellular Biology. 2004 24(9): 3894-3906.
  1. 16.   Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP- 1 transactivation
  2. Yang, H. S.; Knies, J. L.; Stark, C.; Colburn, N. H.
  3. Oncogene. 2003 22(24): 3712-3720.
  1. 17.   A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappa B or ODC transactivation
  2. Yang, H. S.; Jansen, A. P.; Nair, R.; Shibahara, K.; Verma, A. K.; Cmarik, J. L.; Colburn, N. H.
  3. Oncogene. 2001 20(6): 669-676.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel